Tranexamic Acid

In flexible bronchoscopy, tranexamic acid appeared comparable to the standard topical hemostatic agent of adrenaline in stopping iatrogenic bleeding, according to results published in CHEST.

According to results published in the Journal of Bone and Joint Surgery, tranexamic acid may be indicated for the prevention of heterotopic ossification following surgery for elbow trauma.

Topical tranexamic acid may be an alternative to hydroquinone for the long-term management of mild to moderate melasma, according to an expert consensus.

LAS VEGAS — Results showed tranexamic acid may reduce blood loss and transfusion requirements postoperatively among patients who underwent hemiarthroplasty or total hip arthroplasty for pathologic hip fractures.

LAS VEGAS — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Nicola Fabbri, MD, discussed the use of tranexamic acid for patients with metastatic cancer who undergo total hip arthroplasty or hemiarthroplasty.

According to published results, tranexamic acid did not influence pump pressure or improve arthroscopic visualization in patients undergoing rotator cuff repair.

Among patients undergoing elective CABG, infusion of high-dose tranexamic acid modestly reduced the need for red blood cell transfusion and was noninferior to low-dose infusion regarding safety, findings show.

SAN FRANCISCO — Use of IV tranexamic acid during tibial tubercle osteotomy did not significantly impact blood loss or hemarthrosis, opioid consumption, postoperative pain or functional outcomes, according to results presented here.

Tranexamic acid vs. placebo for life-threatening, major and critical organ bleeding in patients undergoing noncardiac surgery.

Results showed tranexamic acid administration was not associated with increased mortality, deep venous thrombosis, pulmonary embolism, myocardial infarction or stroke in high-risk patients with intertrochanteric hip fractures.